Drug Repurposing in Cancer Research

Erscheinungsjahr 2027
ISBN: 978-0-443-45185-0
Verlag: Elsevier Science

Buch, Englisch, 330 Seiten, Format (B × H): 191 mm x 235 mm, Gewicht: 449 g

Drug Repurposing in Cancer Research investigates the innovative use of drug repurposing in oncology, focusing on emerging and re-emerging cancer types. The book provides a comprehensive yet concise overview of current trends, making it an essential resource for academics and professionals in the field. Structured into 21 chapters, the book presents foundational facts alongside practical and clinically relevant data. It covers topics ranging from market dynamics to AI-driven transformations in cancer treatment, highlighting the rapid advancements in oncology. This compilation ensures that readers are equipped with the latest information necessary for effective research and development. For pharmaceutical researchers, biomedical scientists, and clinicians, "Drug Repurposing in Cancer Research" offers valuable insights into the growing demand for innovative cancer treatments. It serves as a timely resource for understanding the potential of repurposed drugs, supporting efforts in cancer prevention and treatment strategies.

Autoren/Hrsg.

Shegokar, Ranjita

Pathak, Yashwant

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie

Inhaltsverzeichnis

1. Drug Repurposing in Liver Cancer
2. Drug Repurposing in Pancreatic Cancer
3. Drug Repurposing in Heart/Cardiac Cancer
4. Drug Repurposing in Bone Cancer
5. Drug Repurposing in Spleen Cancer
6. Drug Repurposing in ENT Cancer
7. Drug Repurposing in Brain/CNS Cancer
8. Drug Repurposing in Skin Cancer
9. Drug Repurposing in Lung Cancer
10. Drug Repurposing in Thorax Cancer
11. Drug Repurposing in Thyroid Cancer
12. Drug Repurposing in Kidney-Adrenal Cancer
13. Drug Repurposing in Urinary Tract Cancer
14. Drug Repurposing in Breast Cancer
15. Drug Repurposing in Colorectal Cancer
16. Drug Repurposing in Blood Cancer
17. Drug Repurposing in Prostate Cancer
18. Drug Repurposing in Ovarian Cancer
19. Drug Repurposing in Stomach and Intestinal Cancer
20. Drug Repurposing in Pleura and Peritoneum Cancer
21. Drug Repurposing in Oral Cancer

Über Autor(innen)

Shegokar, Ranjita
Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)

Pathak, Yashwant
Yashwant Pathak is a Professor at Taneja College of Pharmacy at the University of South Florida, FL, United States. His area of research is nanotechnology, drug delivery systems, and nutraceuticals. He is also an Ad junct Professor at the Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia.